APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dental Anti-inflammatory Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dental Anti-inflammatory Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025198 pages

Choose your research edition.

Industry ResearchDental Anti-inflammatory Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Dental Anti-inflammatory Drugs Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Dental Anti-inflammatory Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dental Anti-inflammatory Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Dental Anti-inflammatory Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Dental Anti-inflammatory Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dental Anti-inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dental Anti-inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dental Anti-inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dental Anti-inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dental Anti-inflammatory Drugs include 3M, Yunnan Baiyao Group, Johnson & Johnson, Merck, Roche, China Resources Double Crane Pharmaceuticals, Hengrui Medicine, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dental Anti-inflammatory Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dental Anti-inflammatory Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dental Anti-inflammatory Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dental Anti-inflammatory Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Dental Anti-inflammatory Drugs Segment by Company

3M

Yunnan Baiyao Group

Johnson & Johnson

Merck

Roche

China Resources Double Crane Pharmaceuticals

Hengrui Medicine

GSK

Bayer

Sunstar

Septodont

DenMat

Colgate-Palmolive

Bausch Health

Acteon

Dental Anti-inflammatory Drugs Segment by Type

Non-steroidal Anti-inflammatory Drugs

Antibiotics

Steroidal Anti-inflammatory Drugs

Others

Dental Anti-inflammatory Drugs Segment by Application

Clinics

Hospitals

Pharmacies

Online Sales

Others

Dental Anti-inflammatory Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dental Anti-inflammatory Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dental Anti-inflammatory Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dental Anti-inflammatory Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dental Anti-inflammatory Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dental Anti-inflammatory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dental Anti-inflammatory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dental Anti-inflammatory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dental Anti-inflammatory Drugs Industry Trends Table 2. Dental Anti-inflammatory Drugs Industry Drivers Table 3. Dental Anti-inflammatory Drugs Industry Opportunities and Challenges Table 4. Dental Anti-inflammatory Drugs Industry Restraints Table 5. Global Dental Anti-inflammatory Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dental Anti-inflammatory Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dental Anti-inflammatory Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Dental Anti-inflammatory Drugs Sales Market Share by Manufacturers Table 9. Global Dental Anti-inflammatory Drugs Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Dental Anti-inflammatory Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dental Anti-inflammatory Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dental Anti-inflammatory Drugs Manufacturers, Product Type & Application Table 13. Global Dental Anti-inflammatory Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dental Anti-inflammatory Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Non-steroidal Anti-inflammatory Drugs Table 17. Major Manufacturers of Antibiotics Table 18. Major Manufacturers of Steroidal Anti-inflammatory Drugs Table 19. Major Manufacturers of Others Table 20. Global Dental Anti-inflammatory Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Dental Anti-inflammatory Drugs Sales by Type (2021-2026) & (k units) Table 22. Global Dental Anti-inflammatory Drugs Sales by Type (2027-2032) & (k units) Table 23. Global Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026) Table 24. Global Dental Anti-inflammatory Drugs Sales Market Share by Type (2027-2032) Table 25. Global Dental Anti-inflammatory Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Dental Anti-inflammatory Drugs Revenue by Type (2021-2026) & (k units) Table 27. Global Dental Anti-inflammatory Drugs Revenue by Type (2027-2032) & (k units) Table 28. Global Dental Anti-inflammatory Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Dental Anti-inflammatory Drugs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Hospitals Table 32. Major Manufacturers of Pharmacies Table 33. Major Manufacturers of Online Sales Table 34. Major Manufacturers of Others Table 35. Global Dental Anti-inflammatory Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Dental Anti-inflammatory Drugs Sales by Application (2021-2026) & (k units) Table 37. Global Dental Anti-inflammatory Drugs Sales by Application (2027-2032) & (k units) Table 38. Global Dental Anti-inflammatory Drugs Sales Market Share by Application (2021-2026) Table 39. Global Dental Anti-inflammatory Drugs Sales Market Share by Application (2027-2032) Table 40. Global Dental Anti-inflammatory Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Dental Anti-inflammatory Drugs Revenue by Application (2021-2026) & (k units) Table 42. Global Dental Anti-inflammatory Drugs Revenue by Application (2027-2032) & (k units) Table 43. Global Dental Anti-inflammatory Drugs Revenue Market Share by Application (2021-2026) Table 44. Global Dental Anti-inflammatory Drugs Revenue Market Share by Application (2027-2032) Table 45. Global Dental Anti-inflammatory Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Dental Anti-inflammatory Drugs Sales by Region (2021-2026) & (k units) Table 47. Global Dental Anti-inflammatory Drugs Sales Market Share by Region (2021-2026) Table 48. Global Dental Anti-inflammatory Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Dental Anti-inflammatory Drugs Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Dental Anti-inflammatory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Dental Anti-inflammatory Drugs Sales by Country (2021-2026) & (k units) Table 52. North America Dental Anti-inflammatory Drugs Sales by Country (2027-2032) & (k units) Table 53. Europe Dental Anti-inflammatory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Dental Anti-inflammatory Drugs Sales by Country (2021-2026) & (k units) Table 55. Europe Dental Anti-inflammatory Drugs Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Dental Anti-inflammatory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Dental Anti-inflammatory Drugs Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Dental Anti-inflammatory Drugs Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Dental Anti-inflammatory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Dental Anti-inflammatory Drugs Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Dental Anti-inflammatory Drugs Sales by Country (2027-2032) & (k units) Table 62. Global Dental Anti-inflammatory Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Dental Anti-inflammatory Drugs Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Dental Anti-inflammatory Drugs Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Dental Anti-inflammatory Drugs Revenue Market Share by Region (2021-2026) Table 66. Global Dental Anti-inflammatory Drugs Revenue Market Share by Region (2027-2032) Table 67. 3M Company Information Table 68. 3M Business Overview Table 69. 3M Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. 3M Dental Anti-inflammatory Drugs Product Portfolio Table 71. 3M Recent Development Table 72. Yunnan Baiyao Group Company Information Table 73. Yunnan Baiyao Group Business Overview Table 74. Yunnan Baiyao Group Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Yunnan Baiyao Group Dental Anti-inflammatory Drugs Product Portfolio Table 76. Yunnan Baiyao Group Recent Development Table 77. Johnson & Johnson Company Information Table 78. Johnson & Johnson Business Overview Table 79. Johnson & Johnson Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Johnson & Johnson Dental Anti-inflammatory Drugs Product Portfolio Table 81. Johnson & Johnson Recent Development Table 82. Merck Company Information Table 83. Merck Business Overview Table 84. Merck Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Merck Dental Anti-inflammatory Drugs Product Portfolio Table 86. Merck Recent Development Table 87. Roche Company Information Table 88. Roche Business Overview Table 89. Roche Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Roche Dental Anti-inflammatory Drugs Product Portfolio Table 91. Roche Recent Development Table 92. China Resources Double Crane Pharmaceuticals Company Information Table 93. China Resources Double Crane Pharmaceuticals Business Overview Table 94. China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolio Table 96. China Resources Double Crane Pharmaceuticals Recent Development Table 97. Hengrui Medicine Company Information Table 98. Hengrui Medicine Business Overview Table 99. Hengrui Medicine Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Hengrui Medicine Dental Anti-inflammatory Drugs Product Portfolio Table 101. Hengrui Medicine Recent Development Table 102. GSK Company Information Table 103. GSK Business Overview Table 104. GSK Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. GSK Dental Anti-inflammatory Drugs Product Portfolio Table 106. GSK Recent Development Table 107. Bayer Company Information Table 108. Bayer Business Overview Table 109. Bayer Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Bayer Dental Anti-inflammatory Drugs Product Portfolio Table 111. Bayer Recent Development Table 112. Sunstar Company Information Table 113. Sunstar Business Overview Table 114. Sunstar Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Sunstar Dental Anti-inflammatory Drugs Product Portfolio Table 116. Sunstar Recent Development Table 117. Septodont Company Information Table 118. Septodont Business Overview Table 119. Septodont Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Septodont Dental Anti-inflammatory Drugs Product Portfolio Table 121. Septodont Recent Development Table 122. DenMat Company Information Table 123. DenMat Business Overview Table 124. DenMat Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. DenMat Dental Anti-inflammatory Drugs Product Portfolio Table 126. DenMat Recent Development Table 127. Colgate-Palmolive Company Information Table 128. Colgate-Palmolive Business Overview Table 129. Colgate-Palmolive Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Colgate-Palmolive Dental Anti-inflammatory Drugs Product Portfolio Table 131. Colgate-Palmolive Recent Development Table 132. Bausch Health Company Information Table 133. Bausch Health Business Overview Table 134. Bausch Health Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Bausch Health Dental Anti-inflammatory Drugs Product Portfolio Table 136. Bausch Health Recent Development Table 137. Acteon Company Information Table 138. Acteon Business Overview Table 139. Acteon Dental Anti-inflammatory Drugs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Acteon Dental Anti-inflammatory Drugs Product Portfolio Table 141. Acteon Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Dental Anti-inflammatory Drugs Distributors List Table 145. Dental Anti-inflammatory Drugs Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Dental Anti-inflammatory Drugs Product Image Figure 2. Global Dental Anti-inflammatory Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dental Anti-inflammatory Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Dental Anti-inflammatory Drugs Sales (2021-2032) & (k units) Figure 5. Global Dental Anti-inflammatory Drugs Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dental Anti-inflammatory Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Non-steroidal Anti-inflammatory Drugs Image Figure 9. Antibiotics Image Figure 10. Steroidal Anti-inflammatory Drugs Image Figure 11. Others Image Figure 12. Global Dental Anti-inflammatory Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Dental Anti-inflammatory Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2032) Figure 15. Global Dental Anti-inflammatory Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Dental Anti-inflammatory Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Dental Anti-inflammatory Drugs Revenue Market Share by Type (2021-2032) Figure 18. Clinics Image Figure 19. Hospitals Image Figure 20. Pharmacies Image Figure 21. Online Sales Image Figure 22. Others Image Figure 23. Global Dental Anti-inflammatory Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Dental Anti-inflammatory Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Dental Anti-inflammatory Drugs Sales Market Share by Application (2021-2032) Figure 26. Global Dental Anti-inflammatory Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Dental Anti-inflammatory Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Dental Anti-inflammatory Drugs Revenue Market Share by Application (2021-2032) Figure 29. North America Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Dental Anti-inflammatory Drugs Sales Market Share by Country (2021-2032) Figure 31. U.S. Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Dental Anti-inflammatory Drugs Sales Market Share by Country (2021-2032) Figure 36. Germany Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Dental Anti-inflammatory Drugs Sales Market Share by Country (2021-2032) Figure 43. China Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Dental Anti-inflammatory Drugs Sales Market Share by Country (2021-2032) Figure 51. Brazil Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Dental Anti-inflammatory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Dental Anti-inflammatory Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Dental Anti-inflammatory Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Dental Anti-inflammatory Drugs Revenue (2021-2032) & (US$ Million) Figure 62. North America Dental Anti-inflammatory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Dental Anti-inflammatory Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Europe Dental Anti-inflammatory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Dental Anti-inflammatory Drugs Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Dental Anti-inflammatory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Dental Anti-inflammatory Drugs Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Dental Anti-inflammatory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Dental Anti-inflammatory Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Dental Anti-inflammatory Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Non-steroidal Anti-inflammatory Drugs
  • Antibiotics
  • Steroidal Anti-inflammatory Drugs
  • Others
Applications
  • Clinics
  • Hospitals
  • Pharmacies
  • Online Sales
  • Others
Companies covered
  • 3M
  • Yunnan Baiyao Group
  • Johnson & Johnson
  • Merck
  • Roche
  • China Resources Double Crane Pharmaceuticals
  • Hengrui Medicine
  • GSK
  • Bayer
  • Sunstar
  • Septodont
  • DenMat
  • Colgate-Palmolive
  • Bausch Health
  • Acteon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dental Anti-inflammatory Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dental Anti-inflammatory Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dental Anti-inflammatory Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dental Anti-inflammatory Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dental Anti-inflammatory Drugs Market Dynamics
  1. 2.1 Dental Anti-inflammatory Drugs Industry Trends
  2. 2.2 Dental Anti-inflammatory Drugs Industry Drivers
  3. 2.3 Dental Anti-inflammatory Drugs Industry Opportunities and Challenges
  4. 2.4 Dental Anti-inflammatory Drugs Industry Restraints
3 Dental Anti-inflammatory Drugs Market by Manufacturers
  1. 3.1 Global Dental Anti-inflammatory Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dental Anti-inflammatory Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dental Anti-inflammatory Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dental Anti-inflammatory Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dental Anti-inflammatory Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dental Anti-inflammatory Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Dental Anti-inflammatory Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dental Anti-inflammatory Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dental Anti-inflammatory Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dental Anti-inflammatory Drugs Tier 1, Tier 2, and Tier 3
4 Dental Anti-inflammatory Drugs Market by Type
  1. 4.1 Dental Anti-inflammatory Drugs Type Introduction
  2. 4.1.1 Non-steroidal Anti-inflammatory Drugs
  3. 4.1.2 Antibiotics
  4. 4.1.3 Steroidal Anti-inflammatory Drugs
  5. 4.1.4 Others
  6. 4.2 Global Dental Anti-inflammatory Drugs Sales by Type
  7. 4.2.1 Global Dental Anti-inflammatory Drugs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Dental Anti-inflammatory Drugs Sales by Type (2021-2032)
  9. 4.2.3 Global Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2032)
  10. 4.3 Global Dental Anti-inflammatory Drugs Revenue by Type
  11. 4.3.1 Global Dental Anti-inflammatory Drugs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Dental Anti-inflammatory Drugs Revenue by Type (2021-2032)
  13. 4.3.3 Global Dental Anti-inflammatory Drugs Revenue Market Share by Type (2021-2032)
5 Dental Anti-inflammatory Drugs Market by Application
  1. 5.1 Dental Anti-inflammatory Drugs Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Pharmacies
  5. 5.1.4 Online Sales
  6. 5.1.5 Others
  7. 5.2 Global Dental Anti-inflammatory Drugs Sales by Application
  8. 5.2.1 Global Dental Anti-inflammatory Drugs Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Dental Anti-inflammatory Drugs Sales by Application (2021-2032)
  10. 5.2.3 Global Dental Anti-inflammatory Drugs Sales Market Share by Application (2021-2032)
  11. 5.3 Global Dental Anti-inflammatory Drugs Revenue by Application
  12. 5.3.1 Global Dental Anti-inflammatory Drugs Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Dental Anti-inflammatory Drugs Revenue by Application (2021-2032)
  14. 5.3.3 Global Dental Anti-inflammatory Drugs Revenue Market Share by Application (2021-2032)
6 Global Dental Anti-inflammatory Drugs Sales by Region
  1. 6.1 Global Dental Anti-inflammatory Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dental Anti-inflammatory Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Dental Anti-inflammatory Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Dental Anti-inflammatory Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dental Anti-inflammatory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dental Anti-inflammatory Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dental Anti-inflammatory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dental Anti-inflammatory Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dental Anti-inflammatory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dental Anti-inflammatory Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dental Anti-inflammatory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dental Anti-inflammatory Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dental Anti-inflammatory Drugs Revenue by Region
  1. 7.1 Global Dental Anti-inflammatory Drugs Revenue by Region
  2. 7.1.1 Global Dental Anti-inflammatory Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dental Anti-inflammatory Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Dental Anti-inflammatory Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Dental Anti-inflammatory Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dental Anti-inflammatory Drugs Revenue (2021-2032)
  8. 7.2.2 North America Dental Anti-inflammatory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dental Anti-inflammatory Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Dental Anti-inflammatory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dental Anti-inflammatory Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dental Anti-inflammatory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dental Anti-inflammatory Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dental Anti-inflammatory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 3M
  2. 8.1.1 3M Company Information
  3. 8.1.2 3M Business Overview
  4. 8.1.3 3M Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 3M Dental Anti-inflammatory Drugs Product Portfolio
  6. 8.1.5 3M Recent Developments
  7. 8.2 Yunnan Baiyao Group
  8. 8.2.1 Yunnan Baiyao Group Company Information
  9. 8.2.2 Yunnan Baiyao Group Business Overview
  10. 8.2.3 Yunnan Baiyao Group Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yunnan Baiyao Group Dental Anti-inflammatory Drugs Product Portfolio
  12. 8.2.5 Yunnan Baiyao Group Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Dental Anti-inflammatory Drugs Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Dental Anti-inflammatory Drugs Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Dental Anti-inflammatory Drugs Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 China Resources Double Crane Pharmaceuticals
  32. 8.6.1 China Resources Double Crane Pharmaceuticals Company Information
  33. 8.6.2 China Resources Double Crane Pharmaceuticals Business Overview
  34. 8.6.3 China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolio
  36. 8.6.5 China Resources Double Crane Pharmaceuticals Recent Developments
  37. 8.7 Hengrui Medicine
  38. 8.7.1 Hengrui Medicine Company Information
  39. 8.7.2 Hengrui Medicine Business Overview
  40. 8.7.3 Hengrui Medicine Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hengrui Medicine Dental Anti-inflammatory Drugs Product Portfolio
  42. 8.7.5 Hengrui Medicine Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GSK Dental Anti-inflammatory Drugs Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Bayer
  50. 8.9.1 Bayer Company Information
  51. 8.9.2 Bayer Business Overview
  52. 8.9.3 Bayer Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bayer Dental Anti-inflammatory Drugs Product Portfolio
  54. 8.9.5 Bayer Recent Developments
  55. 8.10 Sunstar
  56. 8.10.1 Sunstar Company Information
  57. 8.10.2 Sunstar Business Overview
  58. 8.10.3 Sunstar Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sunstar Dental Anti-inflammatory Drugs Product Portfolio
  60. 8.10.5 Sunstar Recent Developments
  61. 8.11 Septodont
  62. 8.11.1 Septodont Company Information
  63. 8.11.2 Septodont Business Overview
  64. 8.11.3 Septodont Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Septodont Dental Anti-inflammatory Drugs Product Portfolio
  66. 8.11.5 Septodont Recent Developments
  67. 8.12 DenMat
  68. 8.12.1 DenMat Company Information
  69. 8.12.2 DenMat Business Overview
  70. 8.12.3 DenMat Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 DenMat Dental Anti-inflammatory Drugs Product Portfolio
  72. 8.12.5 DenMat Recent Developments
  73. 8.13 Colgate-Palmolive
  74. 8.13.1 Colgate-Palmolive Company Information
  75. 8.13.2 Colgate-Palmolive Business Overview
  76. 8.13.3 Colgate-Palmolive Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Colgate-Palmolive Dental Anti-inflammatory Drugs Product Portfolio
  78. 8.13.5 Colgate-Palmolive Recent Developments
  79. 8.14 Bausch Health
  80. 8.14.1 Bausch Health Company Information
  81. 8.14.2 Bausch Health Business Overview
  82. 8.14.3 Bausch Health Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bausch Health Dental Anti-inflammatory Drugs Product Portfolio
  84. 8.14.5 Bausch Health Recent Developments
  85. 8.15 Acteon
  86. 8.15.1 Acteon Company Information
  87. 8.15.2 Acteon Business Overview
  88. 8.15.3 Acteon Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Acteon Dental Anti-inflammatory Drugs Product Portfolio
  90. 8.15.5 Acteon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dental Anti-inflammatory Drugs Value Chain Analysis
  2. 9.1.1 Dental Anti-inflammatory Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dental Anti-inflammatory Drugs Production Mode & Process
  6. 9.2 Dental Anti-inflammatory Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dental Anti-inflammatory Drugs Distributors
  9. 9.2.3 Dental Anti-inflammatory Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst